Letrozole - CISMeF

Preferred Label : Letrozole;

MeSH definition : A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.;

MeSH synonym : 4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile);

MeSH hyponym : CGS-20267; CGS20267; Fémara;

MeSH CAS label : Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-;

MeSH Related Number : 112809-51-5 (Letrozole);

Wikipedia link : https://en.wikipedia.org/wiki/Letrozole;

UNII : 7LKK855W8I;

Details

Origin ID

D000077289;

UMLS CUI

C0246421;

ATC code(s)
- letrozole [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Letrozole [ICD-11 Extension code]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- aromatase inhibitors [MeSH Descriptor]
Record concept(s)
- CGS 20267 [MeSH concept]
- Letrozole [MeSH concept]
- femara [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- letrozole [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients